149 related articles for article (PubMed ID: 130746)
21. Cytotoxic activity of rheumatoid and normal lymphocytes against allogeneic and autologous synovial cells in vitro.
Griffiths MM; Smith CB; Ward JR; Klauber MR
J Clin Invest; 1976 Sep; 58(3):613-22. PubMed ID: 956390
[TBL] [Abstract][Full Text] [Related]
22. Mediation of cytotoxic immune responses against human tumor-associated antigens by xenogeneic immune RNA.
Kern DH; Fritze D; Drogemuller CR; Pilch YH
J Natl Cancer Inst; 1976 Jul; 57(1):97-103. PubMed ID: 1003510
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of cell-mediated cytotoxic reactivity against tumor associated antigens with 125I-iododeoxyuridine labeled target cells.
Oldham RK; Herberman RB
J Immunol; 1973 Dec; 111(6):862-71. PubMed ID: 4750872
[No Abstract] [Full Text] [Related]
24. Restricted autologous lymphocytotoxicity in lung neoplasia.
Vose BM; Vánky F; Fopp M; Klein E
Br J Cancer; 1978 Sep; 38(3):375-81. PubMed ID: 81674
[TBL] [Abstract][Full Text] [Related]
25. Cell-mediated immunity to tumor antigens in patients with renal cell carcinoma.
Cummings KB; Peter JB; Kaufman JJ
J Urol; 1973 Jul; 110(1):31-5. PubMed ID: 4713354
[No Abstract] [Full Text] [Related]
26. Cellular immune reaction to human malignant melanoma and breast carcinoma cells.
Canevari S; Fossati G; Della Porta G
J Natl Cancer Inst; 1976 Apr; 56(4):705-9. PubMed ID: 1255793
[TBL] [Abstract][Full Text] [Related]
27. Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2.
Hersey P; Bindon C; Edwards A; Murray E; Phillips G; McCarthy WH
Int J Cancer; 1981 Dec; 28(6):695-703. PubMed ID: 6977498
[TBL] [Abstract][Full Text] [Related]
28. Lymphocytotoxicity in recurrent aphthous stomatitis. Lymphocytotoxicity for oral epithelial cells in recurrent aphthous stomatitis and Bechet syndrome.
Rogers RS; Sams WM; Shorter RG
Arch Dermatol; 1974 Mar; 109(3):361-3. PubMed ID: 4814937
[No Abstract] [Full Text] [Related]
29. Spontaneous and antibody-dependent cellular cytotoxicity in melanoma patients and healthy control presons.
Peter HH; Knoop F; Kalden JR
Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):263-81. PubMed ID: 134545
[TBL] [Abstract][Full Text] [Related]
30. Peripheral blood lymphocytes from patients with cancer lack interleukin-2 receptors.
Hakim AA
Cancer; 1988 Feb; 61(4):689-701. PubMed ID: 2962732
[TBL] [Abstract][Full Text] [Related]
31. Human tumor cells grown in fetal calf serum and human serum: influences on the tests for lymphocyte cytotoxicity, serum blocking and serum arming effects.
Sulit HL; Golub SH; Irie RF; Gupta RK; Grooms GA; Morton DL
Int J Cancer; 1976 Apr; 17(4):461-8. PubMed ID: 945229
[TBL] [Abstract][Full Text] [Related]
32. Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells.
Heppner G; Henry E; Stolbach L; Cummings F; McDonough E; Calabresi P
Cancer Res; 1975 Aug; 35(8):1931-7. PubMed ID: 1149017
[TBL] [Abstract][Full Text] [Related]
33. Cellular immunity to human breast carcinoma.
Fossati G; Canevari S; Della Porta G; Balzarini GP; Veronesi U
Int J Cancer; 1972 Sep; 10(2):391-6. PubMed ID: 4661095
[No Abstract] [Full Text] [Related]
34. Specific cytotoxicity of a long-term cultured T-cell clone on human autologous mammary cancer cells.
Sato T; Sato N; Takahashi S; Koshiba H; Kikuchi K
Cancer Res; 1986 Sep; 46(9):4384-9. PubMed ID: 3488124
[TBL] [Abstract][Full Text] [Related]
35. In vitro induction of tumor-specific immunity. I. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunized in vitro against syngeneic and allogeneic plasma cell tumors.
Wagner H; Röllinghoff M
J Exp Med; 1973 Jul; 138(1):1-15. PubMed ID: 4541509
[TBL] [Abstract][Full Text] [Related]
36. Immunological studies of women with primary breast carcinoma.
Jeejeebhoy HF
Int J Cancer; 1975 Jun; 15(6):867-78. PubMed ID: 1150343
[TBL] [Abstract][Full Text] [Related]
37. Role of alloantigens in natural killing. Allogeneic but not autologous tumor biopsy cells are sensitive for interferon-induced cytotoxicity of human blood lymphcoytes.
Vánky FT; Argov SA; Einhorn SA; Klein E
J Exp Med; 1980 May; 151(5):1151-65. PubMed ID: 6154767
[TBL] [Abstract][Full Text] [Related]
38. Immunological reactivity in patients with carcinoma of colon.
Nairn RC; Nind AP; Guli EP; Davies DJ; Rolland JM; McGiven AR; Hughes ES
Br Med J; 1971 Dec; 4(5789):706-9. PubMed ID: 4943033
[TBL] [Abstract][Full Text] [Related]
39. The specificity of the microcytotoxicity assay for cell-mediated immunity in human bladder cancer.
Vilien M; Wolf H
J Urol; 1978 Mar; 119(3):338-42. PubMed ID: 273706
[TBL] [Abstract][Full Text] [Related]
40. Lymphocyte-mediated tumor cell destruction in vitro. Some general principles and reactivities in human urinary bladder carcinoma.
Perlmann P; O'Toole C; Unsgaard B
Natl Cancer Inst Monogr; 1972 Dec; 35():223-9. PubMed ID: 4540587
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
